Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Smith

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
Frontiers in Immunology|June 2, 2020
Maternal Latent <i>Mycobacterium tuberculosis</i> Does Not Affect the Infant Immune Response Following BCG at Birth: An Observational Longitudinal Study in UgandaLawrence Lubyayi, Patrice A Mawa, Grace Nabakooza, et al.
Scientific Reports|December 8, 2016
Diverse specificity of cellulosome attachment to the bacterial cell surfaceJoana L A Brás, Benedita A Pinheiro, Kate Cameron, et al.
The Lancet. Oncology|April 3, 2018
Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 studyTheodore W Laetsch, Steven G DuBois, Leo Mascarenhas, et al.
Cancer Research Communications|March 29, 2024
First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid TumorsMark Yarchoan, John D Powderly, Bruno R Bastos, et al.
Mabs|December 15, 2015
CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptorsCon Panousis, Urmi Dhagat, Kirsten M Edwards, et al.
Cell Reports|April 30, 2020
Inhibition of Tumor VEGFR2 Induces Serine 897 EphA2-Dependent Tumor Cell Invasion and Metastasis in NSCLCCaroline Volz, Sara Breid, Carolin Selenz, et al.
Nature|March 16, 2023
The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemiaGhayas C Issa, Ibrahim Aldoss, John DiPersio, et al.
Cancer Research|March 13, 2019
Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in <i>KRAS</i>-Mutant Pancreatic and Colorectal CancerJörn Weisner, Ina Landel, Christoph Reintjes, et al.
Histopathology|July 4, 2025
Interobserver reproducibility of hilar soft tissue invasion in testicular germ cell tumours among genitourinary pathologistsDouglas Jian-Xian Wu, Mahmut Akgul, Sean R Williamson, et al.
The American Journal of Surgical Pathology|July 30, 2025
Interobserver Reproducibility of Pelvicalyceal Invasion in Renal Cell Carcinoma Nephrectomies Among Genitourinary PathologistsAnkur R Sangoi, Mahmut Akgul, Aysha Mubeen, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
Frontiers in Immunology|June 2, 2020
Maternal Latent <i>Mycobacterium tuberculosis</i> Does Not Affect the Infant Immune Response Following BCG at Birth: An Observational Longitudinal Study in UgandaLawrence Lubyayi, Patrice A Mawa, Grace Nabakooza, et al.
Scientific Reports|December 8, 2016
Diverse specificity of cellulosome attachment to the bacterial cell surfaceJoana L A Brás, Benedita A Pinheiro, Kate Cameron, et al.
The Lancet. Oncology|April 3, 2018
Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 studyTheodore W Laetsch, Steven G DuBois, Leo Mascarenhas, et al.
Cancer Research Communications|March 29, 2024
First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid TumorsMark Yarchoan, John D Powderly, Bruno R Bastos, et al.
Mabs|December 15, 2015
CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptorsCon Panousis, Urmi Dhagat, Kirsten M Edwards, et al.
Cell Reports|April 30, 2020
Inhibition of Tumor VEGFR2 Induces Serine 897 EphA2-Dependent Tumor Cell Invasion and Metastasis in NSCLCCaroline Volz, Sara Breid, Carolin Selenz, et al.
Nature|March 16, 2023
The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemiaGhayas C Issa, Ibrahim Aldoss, John DiPersio, et al.
Cancer Research|March 13, 2019
Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in <i>KRAS</i>-Mutant Pancreatic and Colorectal CancerJörn Weisner, Ina Landel, Christoph Reintjes, et al.
Histopathology|July 4, 2025
Interobserver reproducibility of hilar soft tissue invasion in testicular germ cell tumours among genitourinary pathologistsDouglas Jian-Xian Wu, Mahmut Akgul, Sean R Williamson, et al.
The American Journal of Surgical Pathology|July 30, 2025
Interobserver Reproducibility of Pelvicalyceal Invasion in Renal Cell Carcinoma Nephrectomies Among Genitourinary PathologistsAnkur R Sangoi, Mahmut Akgul, Aysha Mubeen, et al.
Pageof 13